Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Reinvestment Rate

Latest as of September 2024: 2.09x

Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Reinvestment Rate of 2.09x as of September 2024, reinvesting $1.92 Million (capex $3.00 plus investments $-1.92 Million) from operating cash flow of $920.06K. Explore capital reinvestment ratio of Kiora Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

2.09x
(Capex + Investments) / Operating CF

Total Reinvested

$1.92 Million
Capex + Investments

Operating Cash Flow

$920.06K
USD

Capital Expenditures

$3.00
USD

Kiora Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kiora Pharmaceuticals Inc across 1 annual periods. Also explore Kiora Pharmaceuticals Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Kiora Pharmaceuticals Inc (2024–2024)

Year-by-year capital reinvestment analysis for Kiora Pharmaceuticals Inc. For live market cap and broader valuation context, see KPRX market cap.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 2.65x $22.67 Million $8.56 Million $6.26K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow